Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR

NCT04254211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2021-04-28

No results posted yet for this study

Summary

This study investigated the association of chronic inflammatory markers with the clinical outcome after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm.

Conditions

  • Inflammation in EVAR

Interventions

OTHER

NLR

neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR)

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Elena Arnaoutoglou, MD, PhD · University of Thessaly

  • Maria Ntalouka, MD · University Hospital of Larissa

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2019-02-01
Completion
2019-11-01

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04254211 on ClinicalTrials.gov